Contact ChineseDrama.info

Name

Email *

Message *

Saturday, 8 December 2018

Drama: Broker


Broker China Drama
Title: Broker
Chinese Title: 掮客 / Qian Ke
Broadcast Date: 2019
Genre: Modern, Romance, Workplace
Language: Mandarin
Episodes: 48
Director: Liu Yizhi
Screenwriter: Fei Huijun, Li Xiaoliang
Production Company: Inlee Media, Yuekai Entertainment
Producer: Jia Shikai, Yang Fan
Origin: China
Source: Adapted from the 2007 novel Fallen Angel by Claire Miao Juan

Love Meter


Synopsis and Plot Summary

A broker with a hidden agenda plots to steal a scientist's research, yet a mutual attraction develops between them.

Qiu Jianing (Victoria Song) is a core member of a research lab spearheaded by the leading pharmaceutical company in the nation. She has devoted her heart and soul to finding answers to scientific problems not only to prove herself but also to secure her country's position in the biological field. As their experiment enters the clinical phase, a new researcher by the name of Zhou Xiaoshan (Leo Luo) joins the team. His sharp acumen and quiet nature attracts Jianing's attention. Similarly, her beauty and strength disrupt the calm in Zhou Xiaoshan's single-minded pursuits. In reality, he is a broker who has walked into their lives for the purposes of stealing Janing's research. Will she be the one to change him?



Fun Facts

  • Episode count was changed from 40 to 48 in the records filed with NRTA (formerly SARFT).


Cast
Broker Victoria Song Qian Victoria Song Qian as Qiu Jianing
Broker Leo Luo Yunxi Leo Luo Yunxi as Zhou Xiaoshan
Broker Xu Kaicheng Xu Kaicheng as Qin Bin
Broker Ding Yiyi Ding Yiyi as Qiu Jiaxin
Broker Sun Jiayu Sun Jiayu as Mo Li
Broker Jiang Xueming Jiang Xueming as Ruan Wenzhao
Broker Morning Chang Morning Chang as Qiu Yaoming
Broker Sui Junbo Sui Junbo as Su Qian
Broker Ning Xiaozhi Ning Xiaozhi as Cha Zhicai

Posters
Broker China Drama
Show more...


Let us know why you like Broker in the comments section. Please also share these fun facts using the social media buttons below.




No comments:

Post a Comment